DECR1 and Obesity: MASLD can be associated with a variety of cardiometabolic, orthopedic and psychological complications already in childhood and adolescence [19]; considering the obesity pandemic with a worldwide obesity rate of approximately 40% in adults [20], and increased overall genetic testing, DECR1 deficiency may be more likely to be recognized in the future.